290 related articles for article (PubMed ID: 21730142)
1. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
[TBL] [Abstract][Full Text] [Related]
2. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac).
Andersen J; Stuhr-Hansen N; Zachariassen LG; Koldsø H; Schiøtt B; Strømgaard K; Kristensen AS
Mol Pharmacol; 2014 May; 85(5):703-14. PubMed ID: 24516100
[TBL] [Abstract][Full Text] [Related]
4. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter.
Larsen MA; Plenge P; Andersen J; Eildal JN; Kristensen AS; Bøgesø KP; Gether U; Strømgaard K; Bang-Andersen B; Loland CJ
Br J Pharmacol; 2016 Mar; 173(5):925-36. PubMed ID: 26699847
[TBL] [Abstract][Full Text] [Related]
6. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.
Andersen J; Ringsted KB; Bang-Andersen B; Strømgaard K; Kristensen AS
Sci Rep; 2015 Oct; 5():15650. PubMed ID: 26503701
[TBL] [Abstract][Full Text] [Related]
7. Putative drug binding conformations of monoamine transporters.
Ravna AW; Sylte I; Kristiansen K; Dahl SG
Bioorg Med Chem; 2006 Feb; 14(3):666-75. PubMed ID: 16216517
[TBL] [Abstract][Full Text] [Related]
8. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
Eildal JN; Andersen J; Kristensen AS; Jørgensen AM; Bang-Andersen B; Jørgensen M; Strømgaard K
J Med Chem; 2008 May; 51(10):3045-8. PubMed ID: 18429609
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
Andersen J; Kristensen AS; Bang-Andersen B; Strømgaard K
Chem Commun (Camb); 2009 Jul; (25):3677-92. PubMed ID: 19557250
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
Ravna AW; Sylte I; Dahl SG
J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.
Okunola-Bakare OM; Cao J; Kopajtic T; Katz JL; Loland CJ; Shi L; Newman AH
J Med Chem; 2014 Feb; 57(3):1000-13. PubMed ID: 24494745
[TBL] [Abstract][Full Text] [Related]
12. Importance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation.
Rannversson H; Wilson P; Kristensen KB; Sinning S; Kristensen AS; Strømgaard K; Andersen J
J Biol Chem; 2015 Jun; 290(23):14582-94. PubMed ID: 25903124
[TBL] [Abstract][Full Text] [Related]
13. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Gould GG; Brooks BW; Frazer A
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):203-10. PubMed ID: 17697042
[TBL] [Abstract][Full Text] [Related]
14. Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity.
Lynagh T; Khamu TS; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):95-107. PubMed ID: 24081522
[TBL] [Abstract][Full Text] [Related]
15. Interrogating the Molecular Basis for Substrate Recognition in Serotonin and Dopamine Transporters with High-Affinity Substrate-Based Bivalent Ligands.
Andersen J; Ladefoged LK; Kristensen TN; Munro L; Grouleff J; Stuhr-Hansen N; Kristensen AS; Schiøtt B; Strømgaard K
ACS Chem Neurosci; 2016 Oct; 7(10):1406-1417. PubMed ID: 27425420
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
Zhang P; Cyriac G; Kopajtic T; Zhao Y; Javitch JA; Katz JL; Newman AH
J Med Chem; 2010 Aug; 53(16):6112-21. PubMed ID: 20672825
[TBL] [Abstract][Full Text] [Related]
17. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.
Henry LK; Field JR; Adkins EM; Parnas ML; Vaughan RA; Zou MF; Newman AH; Blakely RD
J Biol Chem; 2006 Jan; 281(4):2012-23. PubMed ID: 16272152
[TBL] [Abstract][Full Text] [Related]
18. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
[TBL] [Abstract][Full Text] [Related]
19. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Zhao Z; Zhang HT; Bootzin E; Millan MJ; O'Donnell JM
Neuropsychopharmacology; 2009 May; 34(6):1467-81. PubMed ID: 18923402
[TBL] [Abstract][Full Text] [Related]
20. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Takano A; Halldin C; Farde L
Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
